Species-level differences between mice and rats in regards to micronucleus induction with the hypothermia-inducing drug haloperidol
Species-level differences in response to micronucleus induction with haloperidol, a drug that can induce hypothermia, were investigated. Haloperidol was intraperitoneally (i.p.) administered to mice (12.5–50 mg/kg) and rats (25–100 mg/kg), and the rectal temperature was then measured. At every inves...
Gespeichert in:
Veröffentlicht in: | Mutation research 2009-05, Vol.676 (1), p.102-105 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Species-level differences in response to micronucleus induction with haloperidol, a drug that can induce hypothermia, were investigated. Haloperidol was intraperitoneally (i.p.) administered to mice (12.5–50
mg/kg) and rats (25–100
mg/kg), and the rectal temperature was then measured. At every investigated dose, haloperidol transiently decreased the rectal temperature in mice to less than 30
°C. However, the rectal temperature decreased to approximately 34
°C in rats. For micronucleus induction, haloperidol at doses of 25 and 50
mg/kg resulted in a statistically significant increase in micronucleated polychromatic erythrocyte frequency in the 48
h sampling group of mice, but not in rats. In addition, relatively large micronuclei (diameter of micronucleus
>
one-fourth the diameter of the cytoplasm) accounted for 46–47% of the induced micronuclei in mice, suggesting that hypothermia affected the mitotic apparatus. Thus, hypothermia can induce micronuclei
in vivo as a secondary effect, and the hypothermic response to haloperidol in mice was stronger than that of rats. Micronuclei could only be induced in mice during this study. Therefore, species-level differences may exist in regards to micronucleus induction by hypothermia-inducing drugs. |
---|---|
ISSN: | 1383-5718 0027-5107 1879-3592 |
DOI: | 10.1016/j.mrgentox.2009.04.011 |